Anticancer Activities and Mechanisms of Blumea balsamifera Extract in Hepatocellular Carcinoma Cells
Authors:
- 1 January 2008
- journal article
- research article
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 36 (02) , 411-424
Abstract
Blumea balsamifera (also known as sambong), a medicinal plant, is known to improve physiological disorders such as rheumatism and hypertension. However, its anticancer activity has not been well elucidated. In this study, we found that Blumea balsamiferaMeOH extract (BME) induced growth inhibitory activity in rat and human hepatocellular carcinoma cells (McA-RH7777, HepG2, respectively) without cytotoxicity as in with rat hepatocytes used as a normal cell model. BME induced cell cycle arrest at G1 phase via decreases in expression of cyclin-E and phosphorylation of retinoblastoma (Rb) protein in both dose- and time-dependent manners. Furthermore, BME reduced the level of a proliferation related ligand (APRIL) which stimulates tumor cell growth. The anti-proliferative effect of BME was improved slightly but significantly by the treatment with recombinant human APRIL. These findings suggest that BME may have a possible therapeutic potential in hepatoma cancer patients and the depletion of cellular APRIL may be one of the important mechanisms on the growth inhibitory effect of BME.Keywords
This publication has 25 references indexed in Scilit:
- Mechanism of the Anti-Cancer Activity of Zizyphus jujuba in HepG2 CellsThe American Journal of Chinese Medicine, 2007
- An APRIL to remember: novel TNF ligands as therapeutic targetsNature Reviews Drug Discovery, 2006
- Dihydroflavonol BB-1, an extract of natural plant Blumea balsamifera, abrogates TRAIL resistance in leukemia cellsBlood, 2006
- Radical scavenging activity of various extracts and fractions of sweet orange peel (Citrus sinensis)Food Chemistry, 2006
- Caspase-independent apoptosis induced by evening primrose extract in Ehrlich ascites tumor cellsCancer Letters, 2003
- Cellular thiol status-dependent inhibition of tumor cell growth via modulation of retinoblastoma protein phosphorylation by (−)-epigallocatechinCancer Letters, 2002
- The Hallmarks of CancerCell, 2000
- APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell GrowthJournal of Experimental Medicine, 1998
- Regulation of cell proliferation by the E2F transcription factorsCurrent Opinion in Genetics & Development, 1998
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976